Cargando…

Tuberculosis in the era of COVID-19 in India

BACKGROUND AND AIMS: Tuberculosis (TB) still continues to be endemic in various regions of the world, including in India and needs surveillance, clinical assessment, testing, contact tracing, confirmation of diagnosis with supervised or in-supervised treatment regimens for an effective eradication....

Descripción completa

Detalles Bibliográficos
Autores principales: Jain, Vijay Kumar, Iyengar, Karthikeyan P., Samy, David Ananth, Vaishya, Raju
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Diabetes India. Published by Elsevier Ltd. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7387287/
https://www.ncbi.nlm.nih.gov/pubmed/32755848
http://dx.doi.org/10.1016/j.dsx.2020.07.034
_version_ 1783564090867712000
author Jain, Vijay Kumar
Iyengar, Karthikeyan P.
Samy, David Ananth
Vaishya, Raju
author_facet Jain, Vijay Kumar
Iyengar, Karthikeyan P.
Samy, David Ananth
Vaishya, Raju
author_sort Jain, Vijay Kumar
collection PubMed
description BACKGROUND AND AIMS: Tuberculosis (TB) still continues to be endemic in various regions of the world, including in India and needs surveillance, clinical assessment, testing, contact tracing, confirmation of diagnosis with supervised or in-supervised treatment regimens for an effective eradication. We assess the challenges due to COVID- 19 pandemic on management of Tuberculosis and current strategies adopted to mitigate them. METHODS: We carried out a comprehensive review of the literature using suitable keywords such as ‘COVID-19’, ‘Pandemics’, ‘Tuberculosis’ and ‘India’ on the search engines of PubMed, Scopus, Google Scholar and Research Gate in the month of May 2020 during the current COVID-19 pandemic to assess the impact of COVID-19 on management of Tuberculosis. RESULTS: We found considerable disruption in Tuberculosis service provisions both in the primary care and hospital settings. Lockdown, social distancing, isolation strategies and public health guidelines to prevent viral transmission impacted the delivery of all aspects of Tuberculosis care. CONCLUSIONS: COVID-19 pandemic has had a significant impact in the delivery of various tuberculosis prevention, surveillance, and treatment programmes. Lockdown and public health guidelines have resulted in tough challenges in traditional management of tuberculosis and has required reconfiguration of methods to support patients including wider use of remote consultations.
format Online
Article
Text
id pubmed-7387287
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Diabetes India. Published by Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-73872872020-07-29 Tuberculosis in the era of COVID-19 in India Jain, Vijay Kumar Iyengar, Karthikeyan P. Samy, David Ananth Vaishya, Raju Diabetes Metab Syndr Article BACKGROUND AND AIMS: Tuberculosis (TB) still continues to be endemic in various regions of the world, including in India and needs surveillance, clinical assessment, testing, contact tracing, confirmation of diagnosis with supervised or in-supervised treatment regimens for an effective eradication. We assess the challenges due to COVID- 19 pandemic on management of Tuberculosis and current strategies adopted to mitigate them. METHODS: We carried out a comprehensive review of the literature using suitable keywords such as ‘COVID-19’, ‘Pandemics’, ‘Tuberculosis’ and ‘India’ on the search engines of PubMed, Scopus, Google Scholar and Research Gate in the month of May 2020 during the current COVID-19 pandemic to assess the impact of COVID-19 on management of Tuberculosis. RESULTS: We found considerable disruption in Tuberculosis service provisions both in the primary care and hospital settings. Lockdown, social distancing, isolation strategies and public health guidelines to prevent viral transmission impacted the delivery of all aspects of Tuberculosis care. CONCLUSIONS: COVID-19 pandemic has had a significant impact in the delivery of various tuberculosis prevention, surveillance, and treatment programmes. Lockdown and public health guidelines have resulted in tough challenges in traditional management of tuberculosis and has required reconfiguration of methods to support patients including wider use of remote consultations. Diabetes India. Published by Elsevier Ltd. 2020 2020-07-29 /pmc/articles/PMC7387287/ /pubmed/32755848 http://dx.doi.org/10.1016/j.dsx.2020.07.034 Text en © 2020 Diabetes India. Published by Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Jain, Vijay Kumar
Iyengar, Karthikeyan P.
Samy, David Ananth
Vaishya, Raju
Tuberculosis in the era of COVID-19 in India
title Tuberculosis in the era of COVID-19 in India
title_full Tuberculosis in the era of COVID-19 in India
title_fullStr Tuberculosis in the era of COVID-19 in India
title_full_unstemmed Tuberculosis in the era of COVID-19 in India
title_short Tuberculosis in the era of COVID-19 in India
title_sort tuberculosis in the era of covid-19 in india
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7387287/
https://www.ncbi.nlm.nih.gov/pubmed/32755848
http://dx.doi.org/10.1016/j.dsx.2020.07.034
work_keys_str_mv AT jainvijaykumar tuberculosisintheeraofcovid19inindia
AT iyengarkarthikeyanp tuberculosisintheeraofcovid19inindia
AT samydavidananth tuberculosisintheeraofcovid19inindia
AT vaishyaraju tuberculosisintheeraofcovid19inindia